The FDA has approved Alvesco (ciclesonide, from Nycomed) inhalation aerosol for the prophylactic and maintenance treatment of asthma in patients ≥12 years of age. Alvesco is a lung-activated corticosteroid prodrug that inhibits multiple inflammatory cell types and chemicals associated with asthma.

For more information call (973) 514-4240 or visit www.alvesco.com.